C-reactive protein as a prognostic marker for mCRPC

Michael R Abern; Emma H Allott; Stephen J Freedland

doi:10.1111/j.1464-410X.2012.11156.x

C-reactive protein as a prognostic marker for mCRPC

Michael R Abern, Emma H Allott, Stephen J Freedland

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	E469
Journal	BJU International
Volume	110
Issue number	11 Pt B
DOIs	https://doi.org/10.1111/j.1464-410X.2012.11156.x
Publication status	Published - Dec 2012

Keywords

C-Reactive Protein/metabolism
Humans
Male
Orchiectomy
Prostatic Neoplasms/blood
Taxoids/administration & dosage

Access to Document

10.1111/j.1464-410X.2012.11156.x

Cite this

@article{6528c9531f994a8cbe22a5a63ccf9dc0,

title = "C-reactive protein as a prognostic marker for mCRPC",

keywords = "C-Reactive Protein/metabolism, Humans, Male, Orchiectomy, Prostatic Neoplasms/blood, Taxoids/administration & dosage",

author = "Abern, {Michael R} and Allott, {Emma H} and Freedland, {Stephen J}",

year = "2012",

month = dec,

doi = "10.1111/j.1464-410X.2012.11156.x",

language = "English",

volume = "110",

pages = "E469",

journal = "BJU International",

issn = "1464-4096",

publisher = "Wiley-Blackwell",

number = "11 Pt B",

}

TY - JOUR

T1 - C-reactive protein as a prognostic marker for mCRPC

AU - Abern, Michael R

AU - Allott, Emma H

AU - Freedland, Stephen J

PY - 2012/12

Y1 - 2012/12

KW - C-Reactive Protein/metabolism

KW - Humans

KW - Male

KW - Orchiectomy

KW - Prostatic Neoplasms/blood

KW - Taxoids/administration & dosage

U2 - 10.1111/j.1464-410X.2012.11156.x

DO - 10.1111/j.1464-410X.2012.11156.x

M3 - Comment/debate

C2 - 22519959

VL - 110

SP - E469

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 11 Pt B

ER -